15th International Ultmann Chicago Lymphoma Symposium
In-Person Event
May 04 - 05, 2018
Chicago, Illinois, USA
OVERVIEW
15th International Ultmann Chicago Lymphoma Symposium (IUCLS) is organized by The University of Chicago - Center for Continuing Medical Education and will be held during May 04 - 05, 2018 at Kimpton Gray Hotel, Chicago, Illinois, United States of America.
The target audience for this medical event is medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals committed to the diagnosis and treatment of lymphoma. This CME Conference has been approved for a maximum of 13.25 continuing nursing education units.
Conference Description :
The 15th International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of national practicing oncologists, advanced nurse practitioners and physician assistants, nurses, residents, fellows, and the Chicago academic community that includes five academic centers. This year’s program offered in May 2018 represents the 15th IUCLS.
Conference Objectives are :
• Describe the evolving role of cellular therapy in lymphoma treatment.
• Identify new targets and therapeutic agents in lymphoma treatment.
• Recognize the appropriate circumstances in which to use different immune-oncology options for lymphoma treatment.
• Evaluate how new scientific data affects the treatment of Hodgkin lymphoma.
• Discuss the appropriate sequencing of agents in chronic lymphocytic leukemia (CLL) treatment based upon the latest scientific evidence.
• Identify patients in need of central nervous system (CNS) lymphoma prophylaxis using the latest guidelines.
• Distinguish when to employ treatments for various T-cell lymphoma histologies.
• Outline how timing affects the use of CAR-T as a therapeutic option for lymphoma.
The target audience for this medical event is medical hematologists/oncologists, radiation oncologists, pathologists, surgical oncologists, fellows-in-training, oncology nurses, and allied health professionals committed to the diagnosis and treatment of lymphoma. This CME Conference has been approved for a maximum of 13.25 continuing nursing education units.
Conference Description :
The 15th International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of national practicing oncologists, advanced nurse practitioners and physician assistants, nurses, residents, fellows, and the Chicago academic community that includes five academic centers. This year’s program offered in May 2018 represents the 15th IUCLS.
Conference Objectives are :
• Describe the evolving role of cellular therapy in lymphoma treatment.
• Identify new targets and therapeutic agents in lymphoma treatment.
• Recognize the appropriate circumstances in which to use different immune-oncology options for lymphoma treatment.
• Evaluate how new scientific data affects the treatment of Hodgkin lymphoma.
• Discuss the appropriate sequencing of agents in chronic lymphocytic leukemia (CLL) treatment based upon the latest scientific evidence.
• Identify patients in need of central nervous system (CNS) lymphoma prophylaxis using the latest guidelines.
• Distinguish when to employ treatments for various T-cell lymphoma histologies.
• Outline how timing affects the use of CAR-T as a therapeutic option for lymphoma.
KEY DATES
04 May, 2018
Event Start Date
05 May, 2018
Event End Date
SPECIALITIES
NursingHematology Blood and Marrow TransplantOncologySUGGESTED HOTELS
CONFERENCE VENUE
Kimpton Gray HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links